Android app Apple app link

From Davids to Goliaths: the GLP-1R gold rush

By Yahoo! Finance   |   11 months ago
From Davids to Goliaths: the GLP-1R gold rush

GLP-1R drugs saw huge success in 2023, generating $37.2 billion in sales. Novo Nordisk and Eli Lilly dominated the market.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.